-

BTIG Adds Bradford Ainslie to Institutional Equities Division

NEW YORK--(BUSINESS WIRE)--BTIG announced today that Bradford Ainslie has joined the firm as a Managing Director within its Institutional Equities business, and will report to Richard J. Blank Jr., Managing Director and Head of Global Equities at BTIG. Mr. Ainslie will increase the client reach of BTIG and expand the ability of the firm to source liquidity.

Mr. Ainslie brings over 20 years of industry experience to the firm. Prior to BTIG, he was Managing Partner and President at The Brightwood Group. Previously, Mr. Ainslie was an Executive Managing Director and Head of Global Markets at The Reorient Group and an Executive Managing Director and Head of the Asia Equities Sales Trading Desk at Cantor Fitzgerald in Hong Kong. Earlier in his career, he was an Equities Trader at Cantor Fitzgerald and a Financial Advisor at Morgan Stanley.

“We are thrilled to have Brad join our Institutional Equities team,” said Mr. Blank. “His international experience and perspective combined with a differentiated global network will be additive to our sales and trading platform. We look forward to his future contribution across all of our product offerings.”

BTIG’s Institutional Equities team leverages their industry relationships to maximize outcomes for market participants. With access to more than 50 global market centers, BTIG sources liquidity on behalf of its 4,000-plus clients worldwide.

About BTIG

BTIG is a global financial services firm specializing in institutional trading, investment banking, research and related brokerage services. With an extensive global footprint and more than 700 employees, BTIG, LLC and its affiliates operate out of 20 cities throughout the U.S., and in Europe, Asia and Australia. BTIG offers execution, expertise and insights for equities, equity derivatives, ETFs and fixed income, currency and commodities (futures, commodities, foreign exchange, interest rates, credit, and convertible and preferred securities). The firm’s core capabilities include global execution, portfolio, electronic and outsource trading, transition management, investment banking, prime brokerage, capital introduction, corporate access, research and strategy, commission management and more.

Disclaimer: https://www.btig.com/disclaimer. To learn more about BTIG, visit www.btig.com.

Contacts

Media: Jill Gordon
443.668.2055
jgordon@prosek.com

Ariana Crupi
212.738.6142
acrupi@btig.com

BTIG


Release Versions

Contacts

Media: Jill Gordon
443.668.2055
jgordon@prosek.com

Ariana Crupi
212.738.6142
acrupi@btig.com

More News From BTIG

BTIG Expands Consumer Staples Research Coverage with the Addition of Owen Bennett

NEW YORK--(BUSINESS WIRE)--BTIG announced today that Owen Bennett has joined the firm as Managing Director and Consumer Staples Analyst, focusing on the tobacco and beverage sectors. "We are thrilled to welcome Owen to BTIG. His extensive expertise in the tobacco space, coupled with deep industry relationships and a differentiated research approach, will enhance our consumer sector coverage and broaden the insights we offer to clients," said Ryan Serwin, CFA, BTIG's Director of Research. "Owen’...

BTIG Announces Strategic Hire for TMT Investment Banking

NEW YORK--(BUSINESS WIRE)--BTIG announced today that Sasson Darwish has joined the firm as a Managing Director and Co-Head of TMT Investment Banking, alongside Brett Fodero and Steven Marder. This hire underscores BTIG’s long-term commitment to growing its Investment Banking practice—particularly within TMT—while continuing to deliver innovative advisory and capital markets solutions to clients. Mr. Darwish brings more than 25 years of investment banking and corporate leadership experience to B...

BTIG to Host 5th Annual Ophthalmology Day on December 1, 2025

NEW YORK--(BUSINESS WIRE)--BTIG announced today that its 5th Annual Ophthalmology Day will take place on Monday, December 1, 2025. The virtual, one-day event will include thematic panel discussions and one-on-one meetings. The event will be hosted by: Ryan Zimmerman, BTIG Medical Technology Analyst Julian Harrison, BTIG Biotechnology Analyst Thomas Shrader, PhD, CFA, BTIG Biotechnology Analyst Justin Zelin, BTIG Biotechnology Analyst Jeet Mukherjee, BTIG Biotechnology Analyst “We are proud to c...
Back to Newsroom